Background and Objectives Calcineurin-dependent transcriptional pathway has recently been implicated in cardiac hypertrophy. Whether calcineurin inhibition can prevent the development of pressure-overload left ventricular hypertrophy LVH is still controversial. To elucidate this issue, the effects of calcineurin inhibitors on the prevention of pressure-overload LVH were examined in mice. Materials and Methods Pressure overload was induced by transverse aortic contriction TAC in 57 ICR mice. Three different doses of CsA TAC/CsA group, n 21 and FK506 TAC/FK group, n 20 were administered subcutaneously from 2 to 14 days after surgery and 16 mice were treated with vehicle TAC group . Another 60 mice were sham-operated and treated with CsA CsA group, n 19 , FK506 FK group, n 18 or vehicle Control group, n 23 . Results Two weeks after TAC, the LV weight-to-body weight LVW/BW ratio was not significantly different among the Control, CsA and FK groups although it was greater in the TAC group 4.55 0.69 mg/g than in the Control 2.78 0.70 mg/g and other sham-operated groups p 0.00005 . Low-dose CsA 5 mg/ kg/day or FK506 0.6 mg/kg/day injection following TAC did not decrease the LVW/BW ratio. However, intermediate-dose and high-dose CsA 25 and 50 mg/kg/day or FK506 2 and 6 mg/kg/day treatment prevented pressure-overload induced LVH and the degree of LVH inhibition was dose-dependent. Interstitial and/or perivascular fibrosis was remarkably decreased by the administration of intermediate and high doses of calcineurin inhibitors for 2 weeks following TAC. Conclusion Taken together, calcineurin inhibitors, CsA and FK506, attenuated pressure-overload LVH response in a dose-dependent fashion. This data indicates that a
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Korean . ANF mRNA expression of cultured neonatal cardiomyocytes after stimulation with phenylephrine PE was increased in a dose-dependent A and time-dependent fashion B . Hypertrophy of the cultured cardiomyocytes induced by 10 M/mL of PE was attenuated after co-incubation with calcineurin inhibitor, cyclosporine A CsA , for 48 hours C . ANF atrial natriuretic factor. 
